106.962 articles found

Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson's disease.

Yoo SW, Kim JS, Oh YS, Ryu DW, Lee KS.

Neurol Sci · 2019-02-28

DOI: 10.1007/s10072-019-03785-8PMID: 30820762

Anti-ageing and anti-Parkinsonian effects of natural flavonol, tambulin from Zanthoxyllum aramatum promotes longevity in Caenorhabditis elegans.

Pandey T, Sammi SR, Nooreen Z, Mishra A, Ahmad A, Bhatta RS, Pandey R.

Exp Gerontol · 2019-02-28

DOI: 10.1016/j.exger.2019.02.016PMID: 30825547

Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease.

van Wamelen DJ, Podlewska AM, Leta V, Śmiłowska K, Rizos A, Martinez-Martin P, Bloem BR, Chaudhuri KR.

Parkinsonism Relat Disord · 2019-02-28

DOI: 10.1016/j.parkreldis.2019.02.041PMID: 30867088

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.

Shahid M, Kim J, Leaver K, Hendershott T, Zhu D, Cholerton B, Henderson VW, Tian L, Poston KL.

Neurobiol Dis · 2019-02-28

DOI: 10.1016/j.nbd.2019.02.023PMID: 30826425

Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinson’s disease

Whiffin N, Armean IM, Kleinman A, Marshall JL, Minikel EV, Karczewski KJ, Cummings BB, Francioli L, Laricchia K, Wang Q, Guan A, Alipanahi B, Morrison P, Baptista MA, Merchant KM, Genome Aggregation Database Production Team, Genome Aggregation Database Consortium, Ware JS, Havulinna AS, Iliadou B, Lee J, Nadkarni GN, Whiteman C, the 23andMe Research Team, Daly M, Esko T, Hultman C, Loos RJ, Milani L, Palotie A, Pato C, Pato M, Saleheen D, Sullivan PF, Alföldi J, Cannon P, MacArthur DG.

· 2019-02-27

DOI: 10.1101/561472

Parkinson hastalığında derin beyin stimülasyonunun erken dönem sonuçları: olgu sunumu

İbrahimoğlu, Özlem, Akyol, Eda

Cukurova Medical Journal, Vol. 44 No. 4 · 2019-02-27

Rheumatoid Meningitis Presenting With Acute Parkinsonism and Protracted Non-convulsive Seizures: An Unusual Case Presentation and Review of Treatment Strategies.

Pellerin D, Wodkowski M, Guiot MC, AlDhukair H, Blotsky A, Karamchandani J, Vinet E, Lafontaine AL, Lubarsky S.

Front Neurol · 2019-02-27

DOI: 10.3389/fneur.2019.00163PMID: 30873111

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.

Redenšek S, Flisar D, Kojović M, Kramberger MG, Georgiev D, Pirtošek Z, Trošt M, Dolžan V.

J Neuroinflammation · 2019-02-27

DOI: 10.1186/s12974-019-1439-yPMID: 30813952

Hand, foot, and spine deformities in parkinsonian disorders.

Wijemanne S, Jankovic J.

J Neural Transm (Vienna) · 2019-02-27

DOI: 10.1007/s00702-019-01986-1PMID: 30809710

Serum NFL discriminates Parkinson disease from atypical parkinsonisms.

Marques TM, van Rumund A, Oeckl P, Kuiperij HB, Esselink RAJ, Bloem BR, Otto M, Verbeek MM.

Neurology · 2019-02-27

DOI: 10.1212/wnl.0000000000007179PMID: 30814322

High serum neurofilament light chain predicts a worse fate in early parkinsonism.

Akhtar RS, Mano T.

Neurology · 2019-02-27

DOI: 10.1212/wnl.0000000000007194PMID: 30814326

Endosomal trafficking leads the way in Parkinson's disease.

Farrer MJ, Follett J.

Mov Disord · 2019-02-27

DOI: 10.1002/mds.27647PMID: 30812061